German SME manufacturing precision eye-tracking systems for cognitive neuroscience, assistive technology, and human-computer interaction research.
SensoMotoric Instruments (SMI) is a German technology SME that develops and manufactures precision eye-tracking instruments used in scientific and applied research. Their core product — gaze-tracking hardware and accompanying analysis software — allows researchers to capture and measure exactly where, how long, and how a person looks at a stimulus, making them a valued equipment partner for consortia studying cognition, language processing, and human-computer interaction. In EU projects they function as a specialist technology provider: embedding commercial-grade measurement tools into research workflows rather than leading the scientific agenda themselves. Their instruments appear in two distinct application domains: neurolinguistics (tracking eye movements during language and reading tasks) and accessibility computing (enabling hands-free digital control for users with motor impairments).
SMI contributed eye-tracking technology to both PREDICTABLE (cognitive-linguistic research) and MAMEM (eye-based multimedia authoring), indicating this is their defining commercial capability across application contexts.
PREDICTABLE combined eye-tracking with EEG, ERP, and NIRS measurements, suggesting SMI's systems integrate with broader cognitive neuroscience measurement pipelines used in academic research.
MAMEM ('Multimedia Authoring and Management using your Eyes and Mind') applied SMI's eye-tracking to enable hands-free computer control, a direct assistive technology use case.
Both H2020 projects began in 2015, which severely limits any meaningful analysis of evolution over time. Their early engagement spanned two distinct application areas simultaneously: fundamental cognitive neurolinguistics (PREDICTABLE — language disorders and multilingualism, using EEG, NIRS, and eye-tracking) and human-computer interaction (MAMEM — eye-based multimedia authoring for accessibility). There are no later-period keywords or projects in the H2020 dataset, making it impossible to determine whether SMI deepened one of these directions, diversified further, or stepped back from EU-funded research after 2015.
With no recorded H2020 activity beyond their 2015 project entries, it is unclear whether SMI remains active in EU research consortia — prospective partners should verify current availability before building them into a proposal.
SMI participates in EU projects as a specialist contributor, never as coordinator — they have not led a single H2020 project. They embed within established multi-partner consortia and bring a specific commercial technology rather than administrative or scientific leadership. This pattern — joining both a training network (MSCA-ITN) and a research action (RIA) in the same year — suggests they are opportunistic but responsive partners who contribute well-defined tools and exit without long-term consortium obligations.
Across two projects, SMI worked with 20 unique consortium partners spread across 10 countries, a broad European footprint for an SME with only two funded engagements. Their network is research-institution-heavy rather than industry-clustered, reflecting the academic orientation of both projects they joined.
SMI occupies a specific niche as a commercial instrument manufacturer that participates directly in EU research consortia — a role that bridges industrial product development with fundamental science. Few German SMEs of this size combine precision gaze-tracking hardware production with validated participation in cognitive neuroscience and accessibility projects at EU scale. For consortium builders, they offer a commercially available, research-proven measurement technology that strengthens the methodological credibility of a proposal without requiring the consortium to source or develop the instrumentation independently.
